IN8bio, Inc., a pioneering clinical-stage biopharmaceutical company, is thrilled to announce a successful funding round, raising an impressive $12 million to advance its groundbreaking gamma-delta T cell therapies for cancer treatment. With its innovative DeltEx platform, IN8bio harnesses the extraordinary potential of gamma-delta T cells鈥攊mmune cells endowed with the remarkable ability to differentiate between healthy and diseased tissues. This unique capability has positioned IN8bio as a leader in the field, making them the first company to trial genetically modified gamma-delta T cells in clinical settings. The newly acquired funding will be instrumental in further developing IN8bio鈥檚 portfolio of ex vivo-expanded and activated gamma-delta T cell therapies, allowing the company to bring forth novel treatments designed to effectively identify and eliminate tumor cells. This funding marks a significant milestone not only for IN8bio but also for the future of cancer therapies, as the company aims to maximize the therapeutic potential of these versatile immune cells through allogeneic, autologous, and genetically modified approaches. As the need for innovative cancer treatments continues to grow, IN8bio is committed to spearheading advancements in cell therapy that could lead to transformational outcomes for patients battling this devastating disease. For more insights into IN8bio鈥檚 mission and its revolutionary approach to cancer treatment, we invite you to visit www.IN8bio.com.
IN8bio Secures $12 Million in Funding for Cutting-Edge Gamma-Delta T Cell Therapies
Recently funded 路 $12.0MBiopharmaceutical
Get the full IN8bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
